Arrhythmia Disorders

Top Story

2 decades of implantable cardiac devices

2 decades of implantable cardiac devices
September 20, 2017

Twenty years ago is approximately when the first dual-chamber defibrillators were available for use. Up to that point, defibrillators had undergone some advances, including antitachycardia pacing, biphasic shock waveforms and using the implantable cardioverter defibrillator can as an electrode, but only provided ventricular backup pacing from a single ventricular lead. These were not very good at preventing the heart from going too slow, so sometimes we needed to insert a separate pacemaker and defibrillator in the same patient.

In 1997, patients who received implantable cardioverter defibrillators more commonly needed them for secondary prevention, ie, they previously had cardiac arrest or sustained ventricular tachycardia. We were just beginning to put devices in after we had done an electrophysiologic study to prove that someone had the potential to develop ventricular tachycardia. These primary prevention ICDs were mostly used for patients with coronary disease and poor ejection fraction.

In the Journals

Death, cardiac arrest not rare during triathlons

September 18, 2017
The incidence of death or cardiac arrest during triathlons was 1.74 per 100,000 triathletes, with most being middle-aged and older men, according to findings published…
In the Journals

Transvenous pacemaker complications present in 1 in 6 patients by 3 years

September 14, 2017
Complications related to transvenous pacemakers have become more common and contribute to the national health care cost, according to an analysis published in JACC
In the JournalsPerspective

Three new studies show benefit of PFO closure on reduced risk for recurrent stroke

September 13, 2017
New data from the CLOSE, REDUCE and RESPECT trials demonstrated a lower rate of recurrent ischemic stroke after patent foramen ovale closure compared with antiplatelet…
More Headlines »
CME

Cardiovascular Consults: Focus on Atrial Fibrillation and Stroke Prevention, Part 2

This activity is supported by educational grants from Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Takeda, and Pfizer.

Atrial fibrillation (AF) is the most common form of arrhythmia observed in clinical practice. Although not typically…
More »
Video
Meeting News Coverage

VIDEO: Few complications related to same-day discharge in patients implanted with ICDs

May 9, 2016
More »
Resource Centers
Cardiology Today Anniversary Resource Center

Cardiology Today Anniversary Resource Center

Video
Meeting News Coverage

VIDEO: NAVIGATE-X4 trial shows promise of quadripolar lead technology

June 12, 2016
More »
Advertisement
Advertisement